Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Post by TheBuzz21on Mar 06, 2021 4:36am

Patent protection to be tested?

First post from a fellow long suffering holder across the pond. This was in the UK Times this morning and I'd be interested to hear what people think. I read it negatively at first, but think on ...more  
364
Comment by Jthom376on Mar 05, 2021 2:31pm

RE:RE:RE:Q1 updates IMV

Thanks for the responses. I'm a lingering COVID trapped investor that quickly ended up in a massive hole. Hung out for the Q4 release... see lots of upside here so content to stay but as mentioned ...more  
229
Discussion
Comment by Biotech010on Mar 05, 2021 2:22pm

RE:RE:Q1 updates IMV

In my recent discussion with the company we talked about the data and visibility among investors.   For DLBCL we agree with you that the data with the biomarker is great but the comments ...more  
240
Discussion
Comment by alphaseeking001on Mar 05, 2021 11:40am

RE:Q1 updates IMV

I agree with you.  The Ovarian and DLBCL updates I read as very positive so the SP reaction has been very disappointing.  Like many long-term shareholders, I've been frustrated on why ...more  
212
Discussion
Post by Jthom376on Mar 05, 2021 10:31am

Q1 updates IMV

Curious on people's thoughts, maybe because there has been a lot of let downs with this investment.... Ovarian update in Q 4, I saw as very good, yet little impact on stock. DLBCL also was very ...more  
203
Discussion
Comment by LR6852on Mar 04, 2021 1:26pm

RE:Just as a side note

It was only withdrawn for small cell lung cancer
115
Discussion
Comment by alphaseeking001on Mar 04, 2021 1:12pm

RE:Just as a side note

I had seen that as well Qwerty.  I'm sure they would absolutely want that indication back.  Volume seems to have been slowing as we've been dropping here.  Hopefully means a ...more  
147
Discussion
Post by qwerty22on Mar 04, 2021 12:37pm

Just as a side note

Merck has had to withdraw Keytruda as a treatment for lung cancer because its efficacy (in terms of OS) is not so strong.  https://www.clinicaltrialsarena.com/news/merck-withdraws-keytruda-for ...more  
169
Discussion
Comment by qwerty22on Mar 04, 2021 12:04am

RE:RE:AACR abstracts in one weeks time

We'll know on the 10th March.  
113
Discussion
Comment by Jthom376on Mar 03, 2021 8:49pm

RE:AACR abstracts in one weeks time

Is IMV participating? I couldn't verify either way. Saw years past but not 2021
94
Discussion
Post by qwerty22on Mar 03, 2021 4:32pm

AACR abstracts in one weeks time

March 10, 2021: Regular Abstract Titles, Authors, and Text Released (4:30 p.m. ET) March 10, 2021: Late-Breaking and Clinical Trials Abstract Titles and Authors Released (4:30 p.m. ET ...more  
215
Discussion
Post by LR6852on Mar 03, 2021 8:04am

New VP Human Resources

IMV has hired a new VP Human Resources.  Her skills include "change management".  Also interesting is that Marianne Stanford is no longer listed as VP R&D on IMV Management ...more  
298
Comment by qwerty22on Mar 02, 2021 4:30pm

RE:Vaccines

One reason for not going full steam in RSV is it's actually a very difficult indication to get over the line, it's a biotech graveyard. We should be grateful they are cautious there. Sure risk ...more  
191
Discussion
Post by cribbonson Mar 02, 2021 9:17am

Vaccines

Great article, NOVAVAX just failed their Phase 3 RSV clinical trial.  Fred looking for a vaccine partner. March is going to be busy.
214
Discussion
Post by 8inchlynchon Mar 01, 2021 10:00pm

New Article

Link here but uou have to create account so I pasted it. https://www.lifescienceleader.com/doc/canadian-covid-vax-comes-forward-0001 LIFE SCIENCE LEADER Magazine Article| March 1, 2021 Canadian COVID ...more  
431
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities